Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug.
Stevens-Johnson syndrome is a severe mucocutaneous reaction, which can be elicited by various drugs. We present 2 cases with this syndrome associated with ciprofloxacin treatment and review the adverse cutaneous events reported as possibly related to ciprofloxacin treatment in Sweden between 1988 and 2000. Eight cases, excluding ours, of Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme were reported. This implies an annual incidence of these adverse cutaneous events of 0.045 per 100,000 treated patients (assuming an average treatment length of 10 days). One patient died, but ciprofloxacin was not considered to be the major cause of death. Together with previous data from the literature, our report supports the view that ciprofloxacin can cause severe adverse cutaneous events.
Hällgren
Jenny
J
Department of Dermatology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden. jenny.hallgren@ks.se
Tengvall-Linder
Maria
M
Persson
Matty
M
Wahlgren
Carl-Fredrik
CF
D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000890:Anti-Infective Agents / Q000009:adverse effects*; D002939:Ciprofloxacin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015994:Incidence; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000453:epidemiology* / Q000473:pathology; D013548:Sweden / Q000453:epidemiology
D000890:Anti-Infective Agents; D002939:Ciprofloxacin